Retatrutide improves blood sugar levels by enhancing insulin release and reducing glucagon release. Studies in people with diabetes have shown that retatrutide leads to significant reductions in blood sugar levels, along with weight loss. It is well-tolerated and has an acceptable safety profile. These findings highlight the potential of retatrutide in improving blood sugar control in individuals with diabetes. Further research is needed to confirm its effectiveness and long-term effects.